Clene Inc. Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
Clene Inc. (CLNN) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2026-03-17
- Clene Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-12-31 was $0.00.
- Clene Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-09-30 was $0.00.
- Clene Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Clene Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Clene Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Clene Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2024 was $12.50M, a 150.00% increase from fiscal 2023.
- Clene Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2023 was $5.00M, a 58.39% decline from fiscal 2022.
- Clene Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2022 was $12.02M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $0.00 derived: sum of 2 quarters · filed 2026-03-17 | $0.00 derived: sum of 3 quarters · filed 2026-03-17 | $0.00 10-K · filed 2026-03-17 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2026-03-17 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-03-17 | $0.00 derived: sum of 4 quarters · filed 2026-03-17 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-03-17 | $0.00 derived: sum of 3 quarters · filed 2026-03-17 | $6.25M derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $0.00 derived: sum of 2 quarters · filed 2026-03-17 | $6.25M derived: sum of 3 quarters · filed 2026-03-17 | $12.50M 10-K · filed 2026-03-17 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $6.25M derived: sum of 2 quarters · filed 2025-11-13 | $12.50M 10-Q · filed 2025-11-13 | $12.50M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $6.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $12.50M 10-Q · filed 2025-08-14 | $12.50M derived: sum of 3 quarters · filed 2025-08-14 | $12.50M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $6.25M 10-Q · filed 2025-05-07 | $6.25M derived: sum of 2 quarters · filed 2025-05-07 | $6.25M derived: sum of 3 quarters · filed 2025-05-07 | $11.25M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $0.00 derived: sum of 2 quarters · filed 2025-03-24 | $5.00M derived: sum of 3 quarters · filed 2025-03-24 | $5.00M 10-K · filed 2025-03-24 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 | $5.00M derived: sum of 2 quarters · filed 2023-11-07 | $5.00M 10-Q · filed 2024-11-13 | $14.02M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-06-30 | $5.00M 10-Q · filed 2023-08-14 | $5.00M 10-Q · filed 2024-08-07 | $14.02M derived: sum of 3 quarters · filed 2024-05-08 | $19.52M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-03-31 | $5.00M 10-Q · filed 2024-05-08 | $9.02M derived: sum of 2 quarters · filed 2024-05-08 | $14.52M derived: sum of 3 quarters · filed 2024-05-08 | $17.02M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $9.52M derived: sum of 2 quarters · filed 2024-03-13 | $12.02M derived: sum of 3 quarters · filed 2024-03-13 | $12.02M 10-K · filed 2024-03-13 |
| 2022-09-30 | $5.50M 10-Q · filed 2023-11-07 | $8.00M derived: sum of 2 quarters · filed 2023-11-07 | $8.00M 10-Q · filed 2023-11-07 | $8.00M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $2.50M 10-Q · filed 2023-08-14 | $2.50M 10-Q · filed 2023-08-14 | $2.50M derived: sum of 3 quarters · filed 2023-08-14 | $2.50M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-05-12 | $0.00 derived: sum of 3 quarters · filed 2023-05-12 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $0.00 derived: sum of 2 quarters · filed 2023-03-13 | $0.00 10-K · filed 2023-03-13 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |